CLINICAL STUDY PROTOCOL - Moderna
Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older. Study Phase: 3 Objectives: Primary: • To demonstrate the efficacy of mRNA-1273 to prevent COVID-19. • To evaluate the safety and reactogenicity of 2 injections of
Download CLINICAL STUDY PROTOCOL - Moderna
Information
Domain:
Source:
Link to this page:
Documents from same domain
Vaccination Provider Fact Sheet | EUA | Moderna COVID-19 ...
www.modernatx.comPrimary Series: Each primary series dose of the Moderna COVID-19 Vaccine is 0.5 mL. The Moderna COVID-19 Vaccine is administered as a primary series of two doses (0.5 mL each) ... See this Fact Sheet for instructions for preparation and administration. This Fact Sheet may have . Revised: Dec/9/2021 2
COVID-19 Vaccine (mRNA-1273) - Moderna
www.modernatx.comNov 16, 2020 · Pediatric respiratory syncytial virus (RSV) vaccine Future respiratory combo Worldwide mRNA-1189 Epstein-Barr virus (EBV) vaccine Worldwide mRNA-1851 Influenza H7N9vaccine ... Presentation of older adults Phase 1 data October 22, 2020 Phase 3 COVE study completed enrollment of 30,000 participants Sept 29, 2020 Publication of older adults …
Storage Handling - Moderna
www.modernatx.comStorage and Handling The information in this Fact Sheet supersedes the information on the vial and carton labels. During storage, minimize exposure to room light. The Moderna COVID-19 Vaccine multiple-dose vials are stored frozen between -50º to -15ºC (-58º to 5ºF). Store in the original carton to protect from light.
WHITE PAPER mRNA Vaccines - Moderna
www.modernatx.comsyringe Investment decisions in production facility (3-5yr lead time) Standardized (mg scale) Standardized (kg scale) Standardized multiproduct facility (kg scale) mRNA vaccine DNA vaccine: Bespoke facility ($100mm-$1bn) (tonne scale) Specialized delivery system Standard needle &
US00000010898574B220210126
www.modernatx.comTitle: US00000010898574B220210126 Subject: 00780001 Created Date: 20210106010406Z
IMPORTANT PRESCRIBING INFORMATION Booster Dose …
www.modernatx.comreport vaccine administration errors to the Vaccine Adverse Event Reporting System (VAERS). See the Fact Sheet for Vaccination Providers for reporting instructions. Additional Resources To access the most recent Moderna COVID-19 Vaccine Fact Sheets, please scan the QR code or
Vaccine Recipient Fact Sheet | EUA | Moderna COVID-19 …
www.modernatx.comEMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER You are being offered the Moderna COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to …
Reimbursement for the Moderna COVID-19 Vaccine
www.modernatx.comcharge for administration. However, vaccination providers may seek appropriate reimbursement from a program or plan that covers COVID-19 vaccine administration fees for the vaccine recipient (private insurance, Medicare, Medicaid, HRSA COVID-19 Uninsured Program for non-insured recipients).
Moderna COVID-19 Vaccine EUA Letter of Authorization
www.modernatx.comJan 31, 2022 · vaccine in individuals 18 years of age or older who have undergone solid organ transplantation, or individuals 18 years of age or older who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise, FDA reviewed safety and effectiveness data reported in two manuscripts on solid organ transplant recipients.
Hoja informativa para receptores de la vacuna | EUA ...
www.modernatx.comLa vacuna contra la COVID-19 de Moderna es una vacuna no aprobada. En ensayos clínicos, aproximadamente 15,400 personas de 18 años en adelante han recibido al menos 1 dosis de la vacuna contra la COVID-19 de Moderna. Millones de personas han recibido la vacuna en virtud
Related documents
Antenna Height and Communications Effectiveness
www.arrl.orgEffectiveness By R. Dean Straw, N6BV, and Gerald L. Hall, K1TD Senior Assistant Technical Editor and Retired Associate Technical Editor The purpose of this paper is to provide general information about communications effectiveness as related to the physical height of antennas. The intended audience is amateur
Understanding the Difference
www.cdc.govUnderstanding the Difference! WARNING Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam scelerisque leo et eros convallis condimentum.
CAP REGULATION 160 -1 - Civil Air Patrol
www.gocivilairpatrol.comSafety CIVIL AIR PATROL SAFETY PROGRAM Supersedes: CAPR 62-1, 19 December 2012 OPR: SE ... this effort is the on-going assessment of the effectiveness of existing risk controls. 1.2.3. Education and Training. The CAP Safety Program will provide members with education
National Patient Safety Goals Effective July 2020 for the ...
www.jointcommission.org- Evaluating anticoagulation safety practices, taking actions to improve safety practices, and measuring the effectiveness of those actions in a time frame determined by the critical access hospital 6. The critical access hospital provides education to patients and families specific to the anticoagulant medication prescribed, including the ...
OSHA 3220-10N 2004 - Occupational Safety and Health ...
www.osha.govOccupational Safety and Health Administration Think Safety • More than 145,000 people work in over 7,000 warehouses. • The fatal injury rate for the warehousing industry is higher than the national average for all industries. ... maintain and evaluate the effectiveness
Antibiotics & Common Infections
www.rxfiles.caStewardship, Effectiveness, Safety & Clinical Pearls ….1 Bronchitis, Acute ….3 Community Acquired Pneumonia (CAP) ….4 Pharyngitis ….6 Sinusitis, Acute ….8 Oral Antibiotics - General Overview ..10 Pregnancy/Lactation ..10 Oral Antibiotics – Drug Comparison Charts Penicillins ..11 Cephalosporins ..11 Macrolides ..12